Next Article in Journal
Neuroprotective Effect of Dioscin on the Aging Brain
Next Article in Special Issue
Characterization of Tapeworm Metabolites and Their Reported Biological Activities
Previous Article in Journal
The 125Te Chemical Shift of Diphenyl Ditelluride: Chasing Conformers over a Flat Energy Surface
Previous Article in Special Issue
Review of Ethnomedicinal, Phytochemical and Pharmacological Properties of Lannea schweinfurthii (Engl.) Engl.
Open AccessReview

Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials

1
Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY 40292, USA
2
Department of Immunology, Institute of Microbiology, 142 20 Prague, Czech Republic
3
Zdravotní ústav se sídlem v Ústí nad Labem, 400 01 Ústí nad Labem, Czech Republic
*
Author to whom correspondence should be addressed.
Molecules 2019, 24(7), 1251; https://doi.org/10.3390/molecules24071251
Received: 12 March 2019 / Accepted: 28 March 2019 / Published: 30 March 2019
(This article belongs to the Special Issue Discovery of Active Ingredients from Natural Products)
Glucans are part of a group of biologically active natural molecules and are steadily gaining strong attention not only as an important food supplement, but also as an immunostimulant and potential drug. This paper represents an up-to-date review of glucans (β-1,3-glucans) and their role in various immune reactions and the treatment of cancer. With more than 80 clinical trials evaluating their biological effects, the question is not if glucans will move from food supplement to widely accepted drug, but how soon. View Full-Text
Keywords: glucan; drug; immunity; food; supplement; infection; mushrooms glucan; drug; immunity; food; supplement; infection; mushrooms
Show Figures

Figure 1

MDPI and ACS Style

Vetvicka, V.; Vannucci, L.; Sima, P.; Richter, J. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials. Molecules 2019, 24, 1251. https://doi.org/10.3390/molecules24071251

AMA Style

Vetvicka V, Vannucci L, Sima P, Richter J. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials. Molecules. 2019; 24(7):1251. https://doi.org/10.3390/molecules24071251

Chicago/Turabian Style

Vetvicka, Vaclav; Vannucci, Luca; Sima, Petr; Richter, Josef. 2019. "Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials" Molecules 24, no. 7: 1251. https://doi.org/10.3390/molecules24071251

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop